Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of ...

ORANGE, Calif., Aug. 28, 2025 /PRNewswire/ -- Has a new breed of "Pharma Bros" emerged to undermine legitimate providers and potentially put patient safety at risk? They're not hedge fund traders or ...

CHAMPAIGN — Compounding pharmacists don't just customize drugs for individual patients with special needs. As pharmaceutical companies have stopped making some products, compounding pharmacists have ...

To buy Brazil pharma compounder for 51 mln euros Takes top spot in world's largest pharma compound market Shares up 3 percent (Adds details, background, shares) BRUSSELS, July 11 (Reuters) - Belgian ...

DUBLIN--(BUSINESS WIRE)--The "The Impact of Drug Compounding on Pharma" report has been added to ResearchAndMarkets.com's offering. Drug compounding meets unmet clinical needs, widens therapy choice ...

Corporate giants from Amazon to CVS are investing billions into primary-care practices. It’s part of a sweeping shift in U.S. healthcare to a more value-based model. Here’s what that means for doctors ...

Unlike conventional pharmacies, which mostly dispense premade drugs in standard doses, compounding pharmacies make, or "compound," medications on the premises, according to federal guidelines. For ...

The launch of the new website is part of Olympia's broader initiative to modernize its digital infrastructure and deepen its connections within the healthcare industry. This is a key step in the ...

DUBLIN--(BUSINESS WIRE)--The "Compounding Pharmacy Market by Product (Oral, Topical, Parenteral), Compounding Type (Ingredient Alteration, Dosage Alteration ...

Fagron, the leading global player in pharmaceutical compounding, is pleased to announce the completion of University Compounding Pharmacy (UCP), a 503A pharmaceutical compounder focused on the health ...

Acquisition strengthens women's health, hormone therapy, and personalized care services while adding a nationally recognized compounding advocate to the team ATLANTA, Oct. 9, 2025 /PRNewswire/ -- ...

SUGAR LAND, Texas, Dec. 9, 2019 /PRNewswire/ -- QuVa Pharma, Inc. today announced it has signed a production and distribution agreement with Hibernation Therapeutics for its patented cardioplegia ...